Matinas BioPharma Holdings’s (MTNB) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Matinas BioPharma Holdings is a Sell.

Matinas BioPharma Holdings’s (MTNB) 20-Day exponential moving average is 0.63, while Matinas BioPharma Holdings’s (MTNB) share price is $0.57, making it a Sell.

Matinas BioPharma Holdings’s (MTNB) 50-Day exponential moving average is 1.02, while Matinas BioPharma Holdings’s (MTNB) share price is $0.57, making it a Sell.

Advanced Chart >

Matinas BioPharma (MTNB) Pivot Points

Jan 18, 2025, 10:27 PM

Classic

0.52

0.54

0.55

0.56

0.57

0.59

0.60

Fibonacci

0.54

0.55

0.56

0.57

0.58

0.59

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Matinas BioPharma (MTNB) Moving Averages

Jan 18, 2025, 10:27 PM

MA5

0.60Sell

MA10

0.66Sell

0.62Sell

MA20

0.60Sell

0.63Sell

MA50

0.61Sell

1.02Sell

MA100

2.01Sell

2.32Sell

MA200

5.21Sell

5.18Sell

Matinas BioPharma Holdings’s (MTNB) 10-Day exponential moving average is 0.62, while Matinas BioPharma Holdings’s (MTNB) share price is $0.57, making it a Sell.

Matinas BioPharma Holdings’s (MTNB) 100-Day exponential moving average is 2.32, while Matinas BioPharma Holdings’s (MTNB) share price is $0.57, making it a Sell.

Matinas BioPharma Holdings’s (MTNB) stock price is $0.57 and Matinas BioPharma Holdings’s (MTNB) 50-day simple moving average is 0.61, creating a Sell signal.

Matinas BioPharma Holdings’s (MTNB) stock price is $0.57 and Matinas BioPharma Holdings’s (MTNB) 100-day simple moving average is 2.01, creating a Sell signal.

Matinas BioPharma Holdings’s (MTNB) stock price is $0.57 and Matinas BioPharma Holdings’s (MTNB) 200-day simple moving average is 5.21, creating a Sell signal.

Matinas BioPharma (MTNB) Technical Indicators

Jan 18, 2025, 10:27 PM

RSI (14)

44.38

Neutral

STOCH (9,6)

3.94

Buy

STOCHRSI (14)

9.66

Buy

MACD (12,26)

-0.04

Sell

ADX (14)

43.07

Neutral

Williams %R

-90.34

Buy

CCI (14)

-24.14

Neutral

ATR (14)

0.14

Ultimate Oscillator

26.05

Sell

ROC

9.62

Buy

Matinas BioPharma Holdings’s (MTNB) Relative Strength Index (RSI) is 44.38, creating a Neutral signal.

Matinas BioPharma Holdings’s (MTNB) Trend Strength Indicator (ADX) is 43.07, creating a Neutral signal.

Matinas BioPharma Holdings’s (MTNB) Commodity Channel Index (CCI) is -24.14, creating a Neutral signal.

Matinas BioPharma Holdings’s (MTNB) Price Rate of Change (ROC) is 9.62, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is MTNB a Buy, Hold, or Sell?

Based on MTNB’s technical indicators, MTNB is a Strong Sell.

What is MTNB’s RSI (14)?

MTNB’s RSI (14) is 44.38, which suggests MTNB is a Neutral.

What is MTNB’s MACD?

MTNB’s MACD is -0.04, which suggests MTNB is a Sell.

What is MTNB’s 5-day moving average?

MTNB’s 5-day moving average is 0.60, which suggests MTNB is a Sell.

What is MTNB’s 20-day moving average?

MTNB 20-day moving average is 0.60, which suggests MTNB is a Sell.

What is MTNB’s 50-day moving average?

MTNB’s 50-day moving average is 0.61, which suggests MTNB is a Sell.

What is MTNB’s 200-day moving average?

MTNB’s 200-day moving average is 5.21, which suggests MTNB is a Sell.

What is MTNB’s Williams % R (14)?

MTNB’s Williams % R (14) is -90.34, which suggests MTNB is a Buy.

What is MTNB’s CCI (14)?

MTNB’s CCI (14) is -24.14, which suggests MTNB is a Neutral.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing